维普期刊资源整合服务平台（V6.5）

76篇 您的检索式：作者名="FARAG SS"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Natural killer cell receptors:new biology and insights into the graftversus-leukemia effect显示文摘	Farag SS Fehniger TA Ruggeri L	2002	Blood2002，100，6：	1
2	Monoclonal antibodies for the prevention and treatment of graft-versus-host disease显示文摘	Bruner RJ Farag SS	2003	Semin Oncol2003，30，4：	1
3	In vh,o DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies 显示文摘	Farag SS Srivastava S Messina-Graham S	2013	Stem Cells Dev2013，22，7：	1
4	Natural killer cell receptors:new biology and insights into the graft-versus-leukemia effect显示文摘	Farag SS Fehniger TA Ruggeri L	2002	Blood2002，100，6：	1
5	Human natural killer cell development and biology显示文摘	Farag SS Caligiuri MA	2006	Blood Rev2006，20，3：	1
6	Natural killer cell receptors:new biology and insights into the graft-versus-leukemia effect显示文摘	Farag SS Fehniger TA Ruggeri L	2002	Blood2002，100，6：	1
7	Pretreatment cytogeneticsadd to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia:resuits from Cancer and Leukemia Group B 8461 显示文摘	Farag SS Archer KJ Mrozek K	2006	Blood2006，108，1：	1
8	Biology and clinical impact of human natural killer cells显示文摘	Farag SS VanDeusen JB Fehniger TA	2003	Int J Hematol2003，78，1：	1
9	Natural killer cellreceptors: new biology and insights into the graft-versus-leukemia effect显示文摘	Farag SS Fehniger TA Ruggeri L	2002	Blood2002，100，6：	1
10	Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a cancer and leukemia groupBstudy显示文摘	Farag SS Ruppert AS Mr6zek K	2004	Int J Oncol2004，25，1：	1
11	Natural killer cell receptors:new biology and insights into the graft-versus-leukemia effect显示文摘	Farag SS Fehniger FT Ruggeri L	2002	Blood2002，100，6：	1
12	In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies 显示文摘	Farag SS Srivastava S Messina-Graham S	2013	Stem Cells Dev2013，22，7：	1
13	Natural Killer cell receptors new biology and insight into the graft-versus-leukemia effect 显示文摘	Farag SS Fehniger TA Ruggeri L	2002	Blood2002，100，6：	1
14	Natural killer cell receptors:new biology and insights into the graft-versus-leukemia effect显示文摘	Farag SS Fehniger TA Ruggeri L	2002	Blood2002，100，6：	1
15	Biology and clinical impact of human natural killer cells显示文摘	Farag SS Van Deusen JB Fehniger TA	2003	Int J Hematol2003，78，1：	1
16	Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia:Cancer and leukemia group B study 9420显示文摘	Farag SS George SL Lee EJ		0，，09：	1
17	Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia显示文摘	Farag SS Wood LL Schwartz JE		0，，：	1
18	Biology and clinical impact of human nature killer cells显示文摘	Farag SS VanDeusen JB Fehniger TA	2003	Int J Hematol2003，78，1：	1
19	Outcome of induction and postremission therapy in younger aduhs with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study显示文摘	FARAG SS RUPPERT AS MRO' ZEK K	2005	J Clin Oncol2005，23，：	1
20	Natural killer cell re- ceptors: new biology and insights into the graft-versus-leukemia effect显示文摘	Farag SS Fehniger TA Ruggeri L	2002	Blood2002，100，6：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示